Delivery Order SPE2DB22D2007-SPE2DB25FJ2CM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tivicay 50 mg tablets (30-count package) with a ceiling value of $1,334.31. This firm fixed price delivery order, with an ultimate completion date of September 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Tivicay 50 mg tablets (30-count packages) valued at $8,325.46 under a firm fixed price contract. This is a non-set-aside competitive award with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $4,002.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Tivicay 50 mg tablets (30-count packaging). This competitive award, with no set-aside designation, is a firm fixed-price contract that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $20,950.35 to AmerisourceBergen Drug Corp for 30-count bottles of Tivicay 50 mg tablets. This competitive award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tivicay 50 mg tablets in quantities of 30, with a contract ceiling value of $23,342.52. This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $6,671.60 to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg on July 23, 2025, with completion expected by July 24, 2025. This firm fixed price delivery order, with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Tivicay is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract valued at $10,353.99. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count) valued at $2,871.67 on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.11 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Tivicay 50 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $4,178.97. This delivery order represents a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2CMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg with a ceiling value of $11,725.91. Issued on June 6, 2025, this firm fixed-price delivery order is set to be completed by June 9, 2025. The contract will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This award represents a competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical vendor for military and veteran healthcare systems. The company's pharmaceutical supply portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Tivicay, an HIV treatment medication, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare programs through flexible contracting vehicles that enable rapid procurement of essential pharmaceuticals and medical commodities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 6/6/25 |